4888.T
STELLA PHARMA CORPORATION
グロース · 医薬品 · 医薬品 · JP
JPY 358.00
+0.85%Aug 13, 2026, 20:50 UTC
Stella Pharma announced a third-party allotment of 1 million shares to CVI Investments at an issue price of 299 yen per share.
Source:Aug 12, 2026, 00:24 UTC
China Bio-Pharmaceutical Services signed a master cooperation agreement with Stella Pharma to jointly develop and commercialize Steboronine, the world's first approved boron neutron capture therapy drug, in China.